Literature DB >> 3440821

Guanethidine blocks neuropeptide-Y-like inhibitory action of sympathetic nerves on cardiac vagus.

E K Potter1.   

Abstract

In the anaesthetised dog there is prolonged attenuation of cardiac vagal action following electrical stimulation of the cardiac sympathetic nerve or intravenous injection of neuropeptide Y (NPY). The effect survives alpha- and beta-adrenoceptor blockade, and is not mimicked by exogenous noradrenaline. Guanethidine blocks the attenuation of cardiac vagal action following sympathetic stimulation but not after injection of NPY. It is suggested that NPY is released from cardiac sympathetic neurons with noradrenaline following activation of the sympathetic nerve and inhibits cardiac vagal action.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3440821     DOI: 10.1016/0165-1838(87)90095-6

Source DB:  PubMed          Journal:  J Auton Nerv Syst        ISSN: 0165-1838


  5 in total

Review 1.  Dynamic nonlinear vago-sympathetic interaction in regulating heart rate.

Authors:  K Sunagawa; T Kawada; T Nakahara
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  Effects of sympathetic activity and galanin on cardiac vagal action in anaesthetized cats.

Authors:  L G Ulman; E K Potter; D I McCloskey
Journal:  J Physiol       Date:  1992-03       Impact factor: 5.182

3.  Sympathetic-parasympathetic interactions at the heart, possibly involving neuropeptide Y, in anaesthetized dogs.

Authors:  M L Revington; D I McCloskey
Journal:  J Physiol       Date:  1990-09       Impact factor: 5.182

4.  Prolonged inhibition of cardiac vagal action following sympathetic stimulation and galanin in anaesthetized cats.

Authors:  M Revington; E K Potter; D I McCloskey
Journal:  J Physiol       Date:  1990-12       Impact factor: 5.182

5.  Inhibition of cardiac vagal action by galanin but not neuropeptide Y in the brush-tailed possum Trichosurus vulpecula.

Authors:  G P Courtice; E K Potter; D I McCloskey
Journal:  J Physiol       Date:  1993-02       Impact factor: 5.182

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.